Production & Manufacturing

The design and operation of distribution loops for purified water and water for injection are critical to the success of pharmaceutical manufacturing. Maintaining a consistent supply of high-quality water to every point of use requires a balance of pressure,...

In the pharmaceutical sector, the presence of biofilms within water systems represents one of the significant threats to product quality and regulatory compliance. Biofilms are communities of microorganisms that adhere to surfaces and secrete a protective matrix of extracellular...

Modern pharmaceutical manufacturing relies heavily on the purity of its water supply, where organic contaminants can significantly compromise the efficacy and safety of injectable drugs and oral medications. The traditional method of analyzing Total Organic Carbon (TOC) involved the...

Rigorous adherence to Good Manufacturing Practice (GMP) requires that pharmaceutical water systems provide a consistent supply of ultrapure water meeting exact chemical and microbiological specifications. Recent updates to international regulatory frameworks have placed a renewed emphasis on the lifecycle...

President Donald Trump announced plans to implement massive generic drug tariffs starting at 100% in August 2028, scaling up to 200% in August 2029, in an effort to incentivize the pharmaceutical industry to move production to the United States. The...

The global biopharmaceutical contract manufacturing sector is undergoing a rapid transition toward complex modalities as drug developers prioritize specialized treatments for metabolic and chronic conditions. In a major move to consolidate its position within the high-growth peptide market, Samsung...

The modernization of regulatory frameworks is becoming essential to support the pharmaceutical industry’s transition toward advanced production models and to ensure the resilience of global supply chains. As innovative manufacturing technologies emerge, traditional oversight mechanisms must evolve to maintain...